Cipla Ltd.

Cipla has made a firm offer to the board of directors of Medpro to acquire, either through itself or through its nominated subsidiary, 100% of the ordinary shares at a price of ZAR 10.00 per share, and to settle all outstanding share options therein.

Based on Medpro’s current shares and share options outstanding, the total consideration payable by the Company or its nominated subsidiary would be approximately $512 million.

The board of directors of Medpro have recommended to its shareholders to vote in favour of the offer. Also, the independent expert appointed by the Independent board of Medpro is of the opinion the offer is fair and reasonable to the Medpro shareholders.